Patients with more severe T1D require more time for glucose levels to normalize after insulin-induced hypoglycemia and experience prolonged low plasma glucagon levels, highlighting the role of glucagon in managing hypoglycemia [3]. The gene discussed is INS; the disease is type 1 diabetes mellitus.